Agilent Technologies news
The WiseView Research desk's stories that name Agilent Technologies, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The A page →
- HeadlineCarillon Scout Mid Cap Fund Q3 2026 Portfolio Review
- HeadlineAgilent and University of Chicago Launch Center of Excellence for Energy Materials Research
- HeadlineDividend Champion, Contender, And Challenger Highlights: Week October 25
- HeadlineAgilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
- HeadlineIs Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
- HeadlineDividend Champion, Contender, And Challenger Highlights: Week October 4
- HeadlineAgilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
- HeadlineA DCF Analysis: Intrinsic Value $120 vs Price $175
- HeadlineAgilent Technologies (NYSE:A) Hits New 52-Week High – What’s Next?
- HeadlineAgilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
- Insider filingDolsten Mikael sold 634 shares
- CongressJulie Johnson sold $1,001 - $15,000 of A
- CongressJulie Johnson bought $1,001 - $15,000 of A
- Insider filingDolsten Mikael sold 1,600 shares
- CongressRo Khanna bought $1,001 - $15,000 of A
- CongressLisa McClain bought $1,001 - $15,000 of A
- CongressLisa McClain sold $1,001 - $15,000 of A
- CongressJefferson Shreve sold $15,001 - $50,000 of A
- CongressRob Bresnahan bought $1,001 - $15,000 of A
- CongressJulie Johnson sold $1,001 - $15,000 of A
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.